Drug details
Angiomax RTU (bivalirudin injection)
type of Antiplatelet Agents, Hematologic
Angiomax RTU (bivalirudin injection) is a direct thrombin inhibitor indicated for use as an anticoagulant in patients undergoing percutaneous coronary intervention (PCI), including patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome.
This drug may have the following side effects:
- bleeding.